RESQ PHARMACEUTICALS INC. — Form D
RESQ PHARMACEUTICALS INC. of HENDERSON, NV, a company, filed a Form D exempt-offering notice with the SEC on 2021-06-29. The offering totals $10.0M, of which $8.8M was reported sold. Industry: Pharmaceuticals.
Offering
- Filed: 2021-06-29
- Form: D
- Accession: 0001493152-21-015592
- Industry: Pharmaceuticals
- Exemptions: 06b
- Total offering: $10.0M
- Amount sold: $8.8M
- Remaining: $1.2M
- Investors: 52
- Date of first sale: 2021-06-14
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-404660
Issuer
- Name: RESQ PHARMACEUTICALS INC.
- CIK: 0001805243
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2019
- Address: 3535 EXECUTIVE TERMINAL DRIVE, HENDERSON, NV, 89052
- Phone: (701) 541-9222
Officers, directors & promoters (4)
| Name | Role | Location |
|---|
| BEN ESQUE | Director | HENDERSON, NV |
| BEN ESQUE | Executive Officer | HENDERSON, NV |
| John T Hyatt | Promoter | Haleiwa, HI |
| Ben T Esque | Executive Officer | Haleiwa, HI |
Other filings by this issuer (1)
More